Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials

被引：0
|
作者：
Ball, Somedeb [1 ]
Behera, Tapas Ranjan [2 ]
Adhikari, Nimesh [1 ]
Anwer, Faiz [3 ]
Chakraborty, Rajshekhar [3 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA
[3] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
multiple myeloma; carfilzomib; renal adverse events; meta-analysis; MM;
D O I：
10.1016/j.clml.2019.07.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-262
引用
收藏
页码：S332 / S332
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF URETERAL AND RENAL STONES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Matlaga, Brian R.
    Jansen, Jeroen P.
    Meckley, Lisa M.
    Byrne, Thomas W.
    Lingeman, James E.
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A73 - A73
  • [22] Renal insufficiency in multiple myeloma: a systematic review and meta-analysis of all randomized trials from 2005-2019
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Shune, Leyla
    Aziz, Muhammad
    Abdallah, Al-Ola
    McClune, Brian
    Ganguly, Siddhartha
    McGuirk, Joseph
    Kambhampati, Suman
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1386 - 1395
  • [23] A systematic review and meta-analysis of carfilzomib-associated thrombocytopenia as an adverse event in patients with multiple myeloma
    Smrdel, Lara
    Locatelli, Igor
    Zver, Samo
    Gobec, Martina
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [24] Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Zhu, Gui-Qi
    Zou, Zhuo-Lin
    Zheng, Ji-Na
    Chen, Da-Zhi
    Zou, Tian-Tian
    Shi, Ke-Qing
    Zheng, Ming-Hua
    MEDICINE, 2016, 95 (09)
  • [25] Systematic Review, Meta-Analysis and Randomized Controlled Trials in Cytopathology
    AbdullGaffar, Badr
    ACTA CYTOLOGICA, 2012, 56 (03) : 221 - 227
  • [26] injury: A systematic review and meta-analysis of randomized controlled trials
    Daou, Marietou
    Dionne, Joanna C.
    Teng, Jennifer F. T.
    Taran, Shaurya
    Zytaruk, Nicole
    Cook, Deborah
    Wilcox, M. Elizabeth
    JOURNAL OF CRITICAL CARE, 2022, 71
  • [27] Risk of Venous Thromboembolism with Thalidomide in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Gray, Keriann N.
    Chu, David
    Wu, Shenhong
    Lin, Richard Z.
    BLOOD, 2008, 112 (11) : 1305 - 1306
  • [28] Colchicine and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Wang, Michael K.
    Razeghi, Ghazal
    Eikelboom, John W.
    Devereaux, P. J.
    Budgeon, Charley A.
    Jacka, Michael J.
    Wright, David J.
    Latini, Roberto
    Conen, David
    CANADIAN JOURNAL OF CARDIOLOGY, 2024, 40 (07) : 1344 - 1346
  • [29] Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
    Rosenberg, D.
    Avni, T.
    Tsvetov, G.
    Gafter-Gvili, A.
    Diker-Cohen, T.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (10) : 2131 - 2131
  • [30] Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
    Rosenberg, D.
    Avni, T.
    Tsvetov, G.
    Gafter-Gvili, A.
    Diker-Cohen, T.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (03) : 413 - 424
12345